ATI RN
ATI Pharmacology 2016 Practice Exam A Questions
Question 1 of 5
A healthcare provider is caring for several clients who came to the clinic for a seasonal influenza immunization. The provider should identify that which of the following clients is a candidate to receive the vaccine via nasal spray rather than an injection?
Correct Answer: B
Rationale: The correct answer is B. A 17-year-old can receive the influenza vaccine via nasal spray (LAIV) even if they have a hypersensitivity to penicillin, as this is not a contraindication for the influenza immunization. Therefore, in this scenario, the 17-year-old with a hypersensitivity to penicillin is a candidate for the nasal spray vaccine.
Question 2 of 5
A client is starting therapy with raloxifene. Which adverse effect should the client monitor for as instructed by the nurse?
Correct Answer: B
Rationale: In this scenario, the correct answer is B) Hot flashes. Raloxifene is a selective estrogen receptor modulator (SERM) commonly used to prevent and treat osteoporosis in postmenopausal women. Hot flashes are a common adverse effect associated with estrogen-based medications like raloxifene. Leg cramps (Option A) are not typically associated with raloxifene use. Urinary frequency (Option C) is not a common adverse effect of raloxifene. Hair loss (Option D) is also not a known side effect of raloxifene. Educationally, it is important for students to understand the common adverse effects of medications to provide safe and effective care to their patients. Understanding the side effects helps nurses in educating clients about what to expect and how to manage them. In the case of raloxifene, monitoring for hot flashes is crucial for patient education and care.
Question 3 of 5
A client is starting therapy with rituximab. Which of the following findings should the nurse instruct the client to report?
Correct Answer: B
Rationale: In this scenario, the correct answer is B) Fever. When a client is starting therapy with rituximab, it is crucial for the nurse to instruct the client to report any signs of fever promptly. Rituximab is a medication that can suppress the immune system, making the client more susceptible to infections. Fever can be an early sign of infection, which can be severe due to the immunosuppressive effects of rituximab. Option A) Dizziness is not typically associated with rituximab therapy and may be a common side effect of other medications or unrelated issues. Option C) Urinary frequency is also not a common finding associated with rituximab therapy. Option D) Dry mouth is a less concerning side effect compared to fever in this context. Educationally, understanding the side effects and potential complications of rituximab therapy is essential for nurses to ensure the safety and well-being of their clients. Prompt reporting of fever can lead to early intervention and prevention of serious infections in clients undergoing rituximab treatment.
Question 4 of 5
A client with breast cancer is receiving cyclophosphamide. Which of the following findings should the nurse monitor?
Correct Answer: D
Rationale: In the context of a client receiving cyclophosphamide for breast cancer, monitoring for hemorrhagic cystitis is crucial. Cyclophosphamide is a chemotherapy drug known to cause bladder toxicity, leading to hemorrhagic cystitis. This adverse effect can manifest as hematuria, bladder irritation, and potentially serious complications like bladder fibrosis. Monitoring for signs of hemorrhagic cystitis allows for early intervention to prevent further bladder damage and improve the client's quality of life. Hypertension (Option A) is not typically associated with cyclophosphamide use and is not a primary concern when monitoring clients on this medication. Hyperglycemia (Option B) is also not a common side effect of cyclophosphamide and would not be the priority for monitoring in this case. Ototoxicity (Option C) refers to damage to the ears and is not a known side effect of cyclophosphamide, making it an incorrect choice. In an educational context, understanding the specific side effects of chemotherapy drugs like cyclophosphamide is essential for nurses caring for clients with cancer. By knowing which adverse effects to monitor for, nurses can provide safe and effective care, anticipate potential complications, and intervene promptly to promote positive outcomes for their clients.
Question 5 of 5
A healthcare professional is educating a client who is starting therapy with topotecan. Which of the following findings should the professional instruct the client to report?
Correct Answer: C
Rationale: The correct answer is C: 'Sore throat.' Clients starting therapy with topotecan should be instructed to report a sore throat because it can indicate an infection due to the immunosuppressive effects of the medication. Infections can be serious in clients undergoing chemotherapy, so early detection and treatment are crucial to prevent complications.